Literature DB >> 3955583

Postoperative evaluation of endomyocardial fibrosis.

K G Balakrishnan, C G Venkitachalam, V R Pillai, R Subramanian, M S Valiathan.   

Abstract

25 patients with angiographic features suggestive of endomyocardial fibrosis underwent endocardiectomy and atrioventricular valve replacement. There were 8 deaths. 17 survivors were reevaluated after a mean follow-up of 13.5 months. 8 had right ventricular endomyocardial fibrosis (RVEMF) 5 had left ventricular endomyocardial fibrosis (LVEMF) and 4 had biventricular disease (BVEMF). The survivors showed a significant improvement in their clinical features and functional status. There was a significant reduction in atrial size in X-ray. Hemodynamic data showed a significant fall in right heart filling pressure, right ventricular systolic pressure and pulmonary artery mean pressure, and a significant fall in left heart filling pressure in patients with left ventricular disease either alone or as a part of biventricular disease. In ventriculogram, while there was no change in right ventricular shape after endocardiectomy, left ventricular shape was restored to near normal. The significant improvement is mostly due to the correction of the regurgitant lesion and to some extent due to restoration of ventricular compliance.

Entities:  

Mesh:

Year:  1986        PMID: 3955583     DOI: 10.1159/000173987

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  3 in total

1.  [A case of surgical treatment for Löffler's endomyocarditis].

Authors:  M Tamura; M Seki; M Tsubota; M Endo; Y Tsunezuka; H Sato
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-05

2.  A profile of endomyocardial fibrosis.

Authors:  M S Valiathan; K G Balakrishnan; C C Kartha
Journal:  Indian J Pediatr       Date:  1987 Mar-Apr       Impact factor: 1.967

3.  Long-term follow up of patients with endomyocardial fibrosis: effects of surgery.

Authors:  U Schneider; R Jenni; J Turina; M Turina; O M Hess
Journal:  Heart       Date:  1998-04       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.